Cytek Biosciences (CTKB) Income from Non-Controlling Interests (2021 - 2023)
Cytek Biosciences (CTKB) posted Income from Non-Controlling Interests of $235000.0 for Q4 2023, up 200.0% on a QoQ basis from -$235000.0 in Q1 2023, and up 24.34% year-over-year from $189000.0 in Q4 2022.
Cytek Biosciences (CTKB) Income from Non-Controlling Interests (2021 - 2023) Analysis & Trends
Cytek Biosciences' Income from Non-Controlling Interests history runs 3 years deep, the most recent figure standing at $235000.0 for Q4 2023.
- Quarterly Income from Non-Controlling Interests rose 24.34% year-over-year to $235000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $189000.0 (up 62.93% YoY) and the FY2022 annual result came in at -$92000.0, down 453.85% from the prior year.
- Income from Non-Controlling Interests was $235000.0 for Q4 2023 at Cytek Biosciences, up from -$235000.0 in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $315000.0 in Q1 2021 and bottomed at -$235000.0 in Q1 2023.
- A 3-year average of $57125.0 and a median of $65000.0 in 2021 frame the typical range for Income from Non-Controlling Interests.
- Peak annual rise in Income from Non-Controlling Interests reached 626.92% in 2022, while the deepest fall reached 143.49% in 2022.
- Cytek Biosciences' Income from Non-Controlling Interests stood at $26000.0 in 2021, then soared by 626.92% to $189000.0 in 2022, then grew by 24.34% to $235000.0 in 2023.
- Business Quant data shows CTKB's Income from Non-Controlling Interests at $235000.0 in Q4 2023, -$235000.0 in Q1 2023, and $189000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 22.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -5.85 Mn |
| 10 | Cytek Biosciences | 565.66 Mn | 499.96 Mn | 21.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 235,000.00 |
| Mar 31, 2023 | -235,000.00 |
| Dec 31, 2022 | 189,000.00 |
| Sep 30, 2022 | -40,000.00 |
| Jun 30, 2022 | 104,000.00 |
| Mar 31, 2022 | -137,000.00 |
| Dec 31, 2021 | 26,000.00 |
| Mar 31, 2021 | 315,000.00 |